23andMe Holding Co. - SIC # 8071 - MEDICAL LABORATORIES

Ticker Exchange SIC # Website Latest Ticker
ME Nasdaq 8071 https://investors.23andme.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for 23andMe Holding Co.

7 Best Sites Like Ancestry.com to Research Your Family History - Apr 26th, 2024 1:44 am
23andMe to Present Preliminary Efficacy and Biomarker Data for 23ME-00610 at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting - Apr 24th, 2024 8:05 pm
This Technology Company Is Being Acquired at a Shocking 207% Premium -- and These 2 Stocks Could Be Next - Apr 23rd, 2024 9:21 am
23andMe CEO Anne Wojcicki Says She’s Weighing Buyout Bid - Apr 19th, 2024 7:43 pm
Stocks to Watch Thursday: TSMC, Netflix, Nvidia, Tesla - Apr 18th, 2024 3:09 pm
23andMe Stock Jumps on News of Plans to Take It Private - Apr 18th, 2024 2:36 pm
23andMe CEO Anne Wojcicki Plans to Take Company Private - Apr 18th, 2024 2:01 pm
23andMe Jumps as CEO Floats Taking DNA Tester Private - Apr 18th, 2024 2:00 pm
23andMe announces CEO’s intention to pursue a potential take-private - Apr 18th, 2024 12:00 pm
23andMe CEO plans to take company private - Apr 18th, 2024 10:35 am
23andMe CEO Wojcicki considering taking firm private, filing shows - Apr 18th, 2024 3:12 am
Can 23andMe Holding (NASDAQ:ME) Afford To Invest In Growth? - Apr 17th, 2024 4:54 pm
23andMe to Present Data on Two Clinical Stage Immuno-Oncology Programs at the American Association for Cancer Research (AACR) Annual Meeting 2024 - Apr 5th, 2024 8:05 pm
Billionaires Are Snapping Up Beaten-Down 23andMe Stock. Should You Follow Their Lead? - Mar 24th, 2024 7:23 am
23andMe Initiates Phase 1 Clinical Trial for its Dual Mechanism Antibody, 23ME-01473, Targeting ULBP6 - Mar 20th, 2024 11:30 am
23andMe Launches New Feature Connecting Customers to Historical Individuals from Hundreds and Even Thousands of Years Ago - Mar 19th, 2024 12:00 pm
23andMe Launches New Genetic Reports on Common Forms of Cancer - Mar 6th, 2024 12:30 pm
23andMe Announces Three Presentations from Clinical-Stage Immuno-Oncology Programs at the American Association for Cancer Research (AACR) Annual Meeting 2024 - Mar 5th, 2024 9:30 pm
20 Most Valuable Digital Health Companies In The US - Feb 23rd, 2024 10:15 am
Is 23andMe Stock a Smart Buy Right Now? - Feb 13th, 2024 2:53 pm